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Abstract
Cytomegalovirus (CMV) infection is a common infection in adults (seropositive 60–99% globally), and is associated with
cardiovascular diseases, in line with risk factors such as hypertension and atherosclerosis. Several viral infections are linked
to hypertension, including human herpes virus 8 (HHV-8) and HIV-1. The mechanisms of how viral infection contributes to
hypertension or increased blood pressure are not defined. In this report, the role of CMV infection as a cause of increased
blood pressure and in forming aortic atherosclerotic plaques is examined. Using in vivo mouse model and in vitro molecular
biology analyses, we find that CMV infection alone caused a significant increase in arterial blood pressure (ABp)
(p,0.01,0.05), measured by microtip catheter technique. This increase in blood pressure by mouse CMV (MCMV) was
independent of atherosclerotic plaque formation in the aorta, defined by histological analyses. MCMV DNA was detected in
blood vessel samples of viral infected mice but not in the control mice by nested PCR assay. MCMV significantly increased
expression of pro-inflammatory cytokines IL-6, TNF-a, and MCP-1 in mouse serum by enzyme-linked immunosorbent assay
(ELISA). Using quantitative real time reverse transcriptase PCR (Q-RT-PCR) and Western blot, we find that CMV stimulated
expression of renin in mouse and human cells in an infectious dose-dependent manner. Co-staining and
immunofluorescent microscopy analyses showed that MCMV infection stimulated renin expression at a single cell level.
Further examination of angiotensin-II (Ang II) in mouse serum and arterial tissues with ELISA showed an increased
expression of Ang II by MCMV infection. Consistent with the findings of the mouse trial, human CMV (HCMV) infection of
blood vessel endothelial cells (EC) induced renin expression in a non-lytic infection manner. Viral replication kinetics and
plaque formation assay showed that an active, CMV persistent infection in EC and expression of viral genes might underpin
the molecular mechanism. These results show that CMV infection is a risk factor for increased arterial blood pressure, and is
a co-factor in aortic atherosclerosis. Viral persistent infection of EC may underlie the mechanism. Control of CMV infection
can be developed to restrict hypertension and atherosclerosis in the cardiovascular system.
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Introduction
Human cytomegalovirus (HCMV) is a member of the herpes
virus family, and HCMV infection is ranked as one of the most
common infections in adults, with the seropositive rates ranging
from 60–99% globally. Once acquired, the infection persists
lifelong and may undergo periodic reactivation. The infection with
HCMV is associated with cardiovascular diseases, and some
countries have reported low rates of HCMV seropositivity and a
high incidence of atherosclerosis [1–4]. Additionally, several virus
infections are associated with hypertension or an increase of blood
pressure, including human herpesvirus 8 (HHV-8) and HIV-1 in
primary pulmonary hypertension [5–7]. The mechanisms under-
lying how viruses contribute to hypertension have not been
identified. In a mouse model of pulmonary hypertension, a recent
paper has explored the mechanism of pulmonary artery
muscularization and arterial remodeling by inflammation and
the Th2 immune response [8]. Clinical isolates of HCMV have
been shown to infect endothelial cells, and the presence of HCMV
antigens in endothelial cells triggers inflammation and immune
response via secretion of CXC chemokines and recruiting
neutrophils, which are infected by HCMV in the process of
neutrophil transendothelial migration [9].
HCMV infection is also implicated in atherosclerosis, as in the
report that HCMV-seropositive individuals have endothelial
dysfunction and an increased atherosclerosis burden [10]. The
use of the anti-CMV drug, ganciclovir, appears to lower heart
transplant related atherosclerosis [11]. Studies in apolipoprotein
E-knockout mice also show that MCMV infection increases
atherosclerosis [12]. Other clinical studies, however, have not
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atherosclerosis [13–17]. It remains an important investigational
subject, therefore, to define the role of CMV in vascular injury and
atherosclerosis. This could also be mediated by CMV inducing
vascular injury and causing hypertension, which serves as a co-
factor to interact with other factors to induce atherosclerosis. As
atherosclerosis is a complicated event with lipid metabolism,
genetic factors and inflammatory pathways obviously playing
crucial roles, it is important to define that a common widespread
virus, such as CMV, might initiate atherosclerosis or inflammatory
response resulting in vascular injury. This has the potential to lead
to new treatments for vascular disease directed at the antiviral
therapy of CMV or prevention by a vaccine against CMV.
Furthermore, distinguishing the role of CMV infection in vascular
cells and atherosclerosis adds to elucidating the mechanism of
CMV associated cardiovascular diseases (CV), since CMV
infection is reported as a primary factor and directly linked to
CV as in myocardial infarction, stroke, coronary restenosis, or CV
death [18–20].
In this study, we have employed in vivo and in vitro experimental
systems and defined that MCMV infection alone results in a
significant increase of blood pressure. Molecular biology analyses
show that MCMV infection stimulated pro-inflammatory cytokine
expression, which have previously been shown to play a role in an
increase of blood pressure [21–23]. Specifically, we have identified
that CMV infection induced expression of renin in an infection
dose responsive manner in mouse renal cells and in human
vascular endothelial cells. Additionally, an increased angiotensin II
(Ang II) level was detected in mouse serum and in arterial blood
vascular tissues after MCMV infection. This is of great interest,
since renin is known as a rate limiting protein of Renin-Ang-II
system (RAS) and Ang II is the effector peptide that directly binds
to blood vessels, causes vasoconstriction and leads to systemic
hypertension in humans [24–27]. Our studies have defined that
CMV infection alone leads to an increase in blood pressure,
whereas CMV acts as a co-factor, along with high cholesterol diet
to induce atherosclerosis in the mouse aorta. A persistent CMV
infection of EC and an increased pro-inflammatory cytokine
expression, including renin and AngII, may underlie the molecular
mechanism by which CMV infection induced an increase of blood
pressure.
Results
MCMV infection significantly increases blood pressure in
vivo
To identify the relationship between CMV infection and an
increase of blood pressure, we performed a trial study using 48
mice in 4 groups, to compare CMV infection with two other
known risk factors in hypertension: high cholesterol diet and
atherosclerosis. Mice in group 1 were infected by MCMV and
fed a regular diet. Mice in group 2 were mock-infected and
fed a regular diet (control group). Mice in group 3 were
infected by MCMV and fed a high cholesterol diet. Mice in
group 4 were mock-infected and fed a high cholesterol diet
(control group).
The carotid blood pressure (ABp) of each mouse was measured
after 6 weeks of infection by inserting a microtip catheter into the
right carotid artery under anesthesia. Both systolic (each peak) and
diastolic (each nadir) ABp were measured and recorded as the real
time tracing [28,29]. The experimental results show that MCMV
infection alone significantly increased arterial blood pressure,
compared to their counterparts in each control group (Fig. 1A–E,
V-HD vs. HD; V vs. M).
An increase in blood pressure by MCMV infection is
independent of high cholesterol diet and atherosclerosis
As previously reported, high cholesterol diet increases blood
pressure, and an increased blood pressure promotes atherosclerosis
that further exacerbates the hypertension [30–33]. The effects of
CMV infection, however, in relation with these two factors on an
increase of blood pressure remain to be identified. In this study, we
analyzed the role of MCMV infection in an increase of blood
pressure, and the relationship with the two known risk factors that
lead to the hypertension.
By studying the four groups of mice, we found that
independent of the high cholesterol diet, MCMV infection
caused a significant increase of blood pressure, since mice
infected with MCMV and fed a regular diet had a significant
increase in arterial blood pressure in contrast to their control
counterparts (Fig. 1E, V vs. M, p,0.01). Furthermore, MCMV
infection exacerbated the increase of blood pressure caused by
the high cholesterol diet, as mice infected with MCMV and fed
with high cholesterol diet had a significantly higher blood
pressure than the mock infected control mice fed with the same
diet (Fig. 1E, V-HD vs. HD, p,0.05).
In determining the role of MCMV infection in atherosclerosis
and an increase in blood pressure, our data show that MCMV
infection and high cholesterol diet together induced atheroscle-
rotic plaque formation in mouse aortas (Fig. 2A–D). Neither
MCMV infection nor high cholesterol diet alone, however,
caused atherosclerosis during the assay period. Although
atherosclerotic plaque formation required the effects of both
MCMV infection and high cholesterol diet, atherosclerosis was
not a major factor that increased blood pressure, since MCMV
infection alone significantly increased the blood pressure
without the effect on atherosclerosis (Fig. 1E, V vs. M,
p,0.01 and Table 1). Our results suggest that MCMV infection
alone plays an important role in the increase of blood pressure
in vivo. Furthermore, an increase in weight was not a factor in
inducing high blood pressure in the context of MCMV
infection, as mice fed a regular diet weighed the same, whether
MCMV infected or mock-infected. Mice fed a high cholesterol
diet weighed the same, regardless of MCMV infected or not
(Fig. S1).
Author Summary
Cytomegalovirus (CMV) infection is associated with car-
diovascular diseases. The exact mechanisms, however,
remain to be defined. Using both mouse model and cell
culture analyses, we find that CMV infection alone causes
an increase in blood pressure. Additionally, CMV infection
augments the increased blood pressure induced by a high
cholesterol diet. CMV infection alone, however, does not
cause atherosclerosis in aortas. CMV infection along with a
high cholesterol diet, however, causes the classic athero-
sclerotic plaque formation in the main artery connected to
the heart. Further studies show that CMV infection induces
renin and angiotensin II (Ang II) expression in blood and in
vessel cells, in a persistent infection manner. An increased
expression of renin and Ang II has been known to cause an
increase in blood pressure or hypertension in humans.
Expression of viral genes and viral persistent infection of
blood vessel endothelial cells resulting in an increased
expression of inflammatory cytokines, including renin and
Ang II, may underpin the molecular mechanism by which
CMV infection induces an increase in blood pressure.
A Role of CMV Infection in Hypertension
PLoS Pathogens | www.plospathogens.org 2 May 2009 | Volume 5 | Issue 5 | e1000427Figure 1. Tracing blood pressures by carotid artery catheter. A representative blood pressure tracing in a mouse from each assay group is
shown (12 mice were in each group). (A) Mouse infected by MCMV. (B) Mock-infected. (C) Mouse infected by MCMV and fed a high cholesterol diet.
(D) Mouse mock infected and fed a high cholesterol diet. (E) The mean value of ABp from each assay group (mmHg). V-HD: mice infected by MCMV
and fed with a high cholesterol diet. HD: mice mock-infected and fed with a high cholesterol diet. V: mice infected by MCMV and fed with a regular
diet. M: mice mock-infected and fed with a regular diet. Blood pressures in each group were measured at week 10 of experiment. The mean values of
systolic and diastolic pressure were determined and calculated with Chart v4.1.2 software, respectively. Statistical significance between assay groups
was determined with Student’s t test. The base line blood pressure of a mouse from each assay group before MCMV infection is shown in Table S1.
doi:10.1371/journal.ppat.1000427.g001
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levels in mouse blood
Others have previously reported that stimulation of pro-
inflammatory cytokine expression increases blood pressure [21–
23]. To identify whether MCMV infection had triggered
expression of pro-inflammatory cytokines and contributed to the
increase of blood pressure, we studied the levels of three cytokines
in mouse blood by cytokine specific ELISA.
The serum levels of IL-6, TNF-a and MCP-1 were significantly
increased in mice infected with MCMV than in mice mock-
infected (Fig. 3A–C; P,0.001, ,0.001 and ,0.01, respectively).
Specifically, diet had no impact on expression of these cytokines in
mice infected by MCMV, in comparison to the control mice
(P.0.05). These results indicate that MCMV infection triggered a
significant increase of pro-inflammatory cytokine expression in
mouse blood, which might participate in the blood pressure
increase induced by CMV infection in vivo.
MCMV infection stimulates expression of renin
Besides determining the increased expression of inflammatory
cytokines, we examined whether CMV infection triggered factors
that are known to regulate blood pressure. Renin is the first and a
step-limiting protein of RAS. RAS plays a central role in
regulating blood pressure. An increased RAS activity leads to an
increase of blood pressure or systemic hypertension [24–27].
To define whether MCMV infection increased expression of
renin, we conducted an in vitro study by using As4.1 cells. These
cells have a basal level expression of renin from the endogenous
Ren-1c locus, and As4.1 cells are kidney cells. We infected As4.1
cells by MCMV in differing multiplicities of infection (MOI), and
detected renin expression by immunofluorescent microscopy.
MCMV infection stimulated renin expression in cells in a
MCMV infection dose dependent manner (Fig. 4A–D). Cells
with mock infection only had a basal level expression of renin.
Since renin generated in kidney cells is the key component of
circulatory RAS, our data suggest that CMV infection stimulated
RAS activity and contributed to an increase of blood pressure in
vivo.
To further define the relationship between MCMV infection
and expression of renin, we performed a co-staining assay to
measure MCMV infection inducing expression of renin at a
single cell level. We find that the induced renin expression
occurred in MCMV infected cells only, and the MCMV antigens
were co-localized with renin in the infected cells that were
detected by antibodies specific to MCMV and renin, respectively
(Fig. 4E–G). Mock-infected cells only had a basal level
expression of renin, and no MCMV antigens were detected
(Fig. 4H–J). When UV-inactivated MCMV was employed as a
control in the infection, no increase in renin expression was
detected (data not shown).
MCMV infection induced expression of Ang II in mouse
blood and artery tissues
Ang II is the main effector peptide of RAS. Ang II directly binds
to receptors on blood vessels and causes vasoconstriction and an
increase of blood pressure [24–27]. To determine whether
MCMV infection also changed expression of Ang II, we examined
Ang II levels in mouse serum and in artery tissues. MCMV
infection alone increased angiotensin II (Ang II) level in mouse
serum. Additionally, MCMV infection exacerbated the increased
Ang II level induced by high cholesterol diet (Fig. 5A). A similar
pattern of Ang II level was detected in arterial tissue specimens.
Despite a high basal level of Ang II expression in artery tissues,
Figure 2. An increase in blood pressure by MCMV infection is independent of atherosclerosis. (A) Aortic root section from a mouse
mock-infected and fed a high cholesterol diet showing no visible atherosclerosis. (B) Aortic root section from a mouse infected by MCMV plus fed a
high cholesterol diet showing a typical atherosclerotic plaque with numerous foam cells and occasional cholesterol clefts. (C) Aortic root section from
a mouse mock-infected and fed a regular diet showing no visible atherosclerosis. (D) Aortic root section from a mouse infected by MCMV and fed a
regular diet showing intimal thickenings (arrow pointed) and no visible atherosclerosis. Each group contained 12 mice. All pictures were taken at 206
magnification, and scales are as shown in bar. The vessel wall was measured in the same position (red arrow pointed) of the aortic root of animals fed
a high cholesterol diet alone (4 mm), MCMV infected plus fed on a high cholesterol diet (7 mm), fed a regular diet alone (3 mm), and MCMV infected
plus fed on a regular diet (6 mm).
doi:10.1371/journal.ppat.1000427.g002
Table 1. Atherosclerotic plaque formation in mouse aorta.
Experimental group Mice
Mouse with
atherosclerotic
plaques P
MCMV (V) 12 0
Mock-infected (M) 12 0
MCMV + High cholesterol diet
(V+HD)
12 3
vs ,0.01
High cholesterol diet (HD) 12 0
doi:10.1371/journal.ppat.1000427.t001
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PLoS Pathogens | www.plospathogens.org 5 May 2009 | Volume 5 | Issue 5 | e1000427MCMV infection alone increased expression of Ang II in aorta
samples and also exaggerated an increased expression of Ang II
induced by high cholesterol diet (Fig. 5B). These results suggest
that CMV infection induced renin and Ang II expression, and this
underlies a molecular mechanism by which CMV infection causes
an increase of blood pressure.
Figure 4. MCMV infection induced expression of renin in a dose dependent manner. (A) Antibody control. Cells were stained at day 6 post
CMV infection at multiplicity of infection (MOI)=10, with a non-specific IgG as the first antibody. (B) Mock infection control (MOI=0). Cells were
stained at day 6 post mock infection by renin specific IgG as the first antibody. Renin was detected at a low level, with positive fine granules suffused
in the cytoplasm, as As4.1 cells have a basal level expression of renin from Ren-1c locus. (C) MCMV infection in a low dose (MOI=1). Cells were stained
at day 6 post infection. Renin positive granules were big, around the nucleus. (D) MCMV infection in a high dose (MOI=10). Cells were stained at day
6 post infection, and renin positive granules were bigger and denser, surrounding the nucleus. (E–G) Co-staining of MCMV and renin. (E) MCMV
antigens were stained in red with TRITC by anti-MCMV antibodies. (F) Renin was stained in green with FTIC by anti-renin antibodies. (G) Overlay the
staining of TRITC and FTIC to show MCMV and renin co-localization in cells. The yellow spots, representing the co-stain of MCMV antigen and renin,
surrounded the nucleus (arrow pointed). (H–J) Controls of immunofluorescent staining. (H) Mock-infected cells stained by anti-MCMV antibodies with
TRITC, no MCMV antigen was detected. (I) Mock-infected cells stained by anti-renin antibody with FTIC, only basal level expression of renin was
detected. (J) Overlay of TRITC and FTIC in mock-infected cells, and no MCMV antigen signal was detected.
doi:10.1371/journal.ppat.1000427.g004
Figure 3. MCMV infection stimulated expression of pro-inflammatory cytokines in mouse serum. The systemic changes on IL-6, TNF-a
and MCP-1 levels in 4 experimental groups were determined by ELISA (each open circle represents a mouse). (A) IL-6 in mice infected with MCMV was
significantly higher than in the mock-infected groups fed with either diet (P,0.001). (B) TNF-a level in mice infected with MCMV was significantly
higher than in the mock-infected groups fed with either diet (P,0.001). (C) MCP-1 level in mice infected with MCMV was significantly higher than in
the mock-infected groups fed with either diet (P,0.01). Statistical significance between assay groups was determined with Student’s t test, and each
group contained 12 mice.
doi:10.1371/journal.ppat.1000427.g003
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infection
During the experimental period, all mice exhibited normal
behavior, eating and drinking activities, without symptoms of
acute MCMV infection such as corneal inflammation/ulcers or
the organ failures shown in immune compromised individuals.
These observations suggest that a persistent or non-lytic viral
infection occurred in the experimental mice, which is typically
observed in immune competent subjects with a CMV infection
[1,34–36]. To examine whether this was the case, we studied three
kinds of blood vessel samples of all 48 mice by histological analysis.
No lesion of lytic MCMV infection was found in blood vessel
samples of viral infected mice, compared to their control
counterparts. A representative result of histological examination
in aorta section of mouse infected by MCMV vs. of mouse mock-
infected has been shown in Fig. 2C and D.
To confirm that CMV infection did occur in blood vessels of
assay mice, we examined the expression of viral mRNA in mouse
aorta in a separate experiment. At week 3 of infection, two mice in
each of the four groups were examined for expression of MCMV
IE1 mRNA in aortic tissues. The MCMV IE1 mRNA was
detected only in viral infected mice but not in the control mice by
RT-PCR assay (Fig. S2). We then examined expression of viral
genomic DNA in blood vessels of experimental mice after 6 weeks
of infection, as CMV is a DNA virus that replicates by amplifying
its genomic DNA in the target cells even with a non-lytic infection.
After examination of MCMV DNA in samples of aortic root,
thoracic aorta, carotid, and post cava vein by PCR analysis, we
found that the 23 out of 24 mice infected by MCMV had viral ie1
DNA detected in the majority of aortas (96%) and in postcaval
venous tissues (100%, Fig. 6, Table 2). No MCMV DNA was
detected in mice that were mock-infected (Fig. 6, Table 2). These
results support that CMV infection of blood vessel cells and
expression of viral RNA and DNA played an important role in
inducing the increase of blood pressure, potentially by altering
expression of host cell genes that are involved in expression of pro-
inflammatory cytokines, renin and Ang II, affecting vessel cell
function and resulting in an increase of blood pressure.
HCMV infection stimulates renin expression in vascular
endothelial cells (EC)
CMV infection is highly cell and species specific, and HCMV
infects only human cells but not mouse cells, and vice versa. To
define whether HCMV infection is a risk factor inducing an
increase of blood pressure in humans, we defined HCMV
infection of both arterial and venous vascular endothelial cells,
by an established in vitro culture system. In addition, expression of
renin in EC is recognized as a key component of the local RAS
[24–27].
Employing human umbilical vein (HUVEC, ATCC) and
abdominal aorta endothelial cells (HAAE, ATCC), we found that
HCMV infection stimulated expression of renin in EC in an
infectious dose dependent manner, determined by expression of
renin mRNA with Q-RT-PCR and expression of renin protein by
Western blot (Fig. 7A–C). In contrast, the HCMV laboratory
strain AD-169, which does not replicate in EC and expresses a
minimal level of pol, did not induce renin expression (Fig. 7C and
D). When EC were exposed to UV-inactivated HCMV, no
increased expression of renin mRNA was detected (data not
shown). Additionally, consistent with the findings of our mouse
trial study, HCMV infection of both arterial and venous EC
showed a non-lytic infection, determined by the absence of cell
cytopathic effect (CPE) or viral plaque formation (Fig. S3, Fig. S4).
HCMV persistently infects EC
To further clarify that HCMV infects EC in a persistent
infection manner, we determined CMV early gene transcripts in
EC by infecting cells with HCMV clinical isolates BI-4 and BI-5,
in contrast to the lab strain AD169. Our data show that, compared
to AD169, HCMV clinical isolates infected EC and expressed two
key genes that were important for CMV replication, ie2 and pol.
The CMV mRNA of ie2 and pol were detected in EC infected by
HCMV clinical isolates (BI-4 and BI-5), but not by the lab strain
(AD169) (Fig. 8). Furthermore, in a multi time-point CMV
infection kinetic study, we defined that HCMV clinical isolates
Figure 5. MCMV infection increased Ang II level in mouse
serum and artery tissues. (A) MCMV infection increased angiotensin
II (Ang II) level in mouse serum, and exacerbated the Ang II level
induced by a high cholesterol diet. Each group contained 12 mice. (B)
MCMV infection increased Ang II levels in aorta tissues, and exacerbated
the Ang II level induced by a high cholesterol diet. Each dot represents
a mouse from each assay group.
doi:10.1371/journal.ppat.1000427.g005
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of pol gene were quantitatively detected in cell culture supernatant,
in contrast to the copy numbers of pol expression from AD169
known to be unable to replicate in EC (Fig. S5).
Taken together, our studies demonstrated that a persistent
HCMV infection, not a lytic infection, plays a central role in
vascular injury associated with HCMV. Specifically, a lytic
infection is defined as evidence of viral replication that leads to
a cytopathic effect, viral plague formation in tissue culture, and cell
lysis with histologic evidence showing morphological cytopathic
change in the mouse vessel walls. A persistent or non-lytic infection
is defined as the evidence of viral gene expression, on DNA, RNA
or protein levels, in the absence of viral cytopathic effect, cell lysis,
or histological changes. We found that the results of cell culture
assay are consistent with the observations of in vivo mouse model
study, since no plaque formation was found in cell culture and no
lytic lesions were observed in mouse aortas with microscopic
analyses. Additionally, HCMV infection of EC further showed
that CMV infection perturbed host cell gene expression, and the
chronic inflammatory responses play a pivotal role in human
cardiovascular diseases initiated by HCMV infection, specifically
an increase of arterial blood pressure that was identified by our in
vivo mouse model studies.
Discussion
MCMV infection caused a significant increase of arterial blood
pressure in vivo, independent of high cholesterol diet and
atherosclerotic plaque formation in the mouse aorta (Fig. 1,
Fig. 2, Tables 1 and 2). Additionally, we find that besides
stimulating expression of inflammatory cytokines reported to
increase blood pressure, CMV infection stimulated expression of
renin, the first component of RAS, in both kidney cells and EC, in
a dose-dependent manner (Fig. 4, Fig. 7). CMV infection also
increased Ang II levels in mouse blood and artery tissues. Ang II
has been known as the effector peptide of RAS that directly binds
to blood vessels and induces vasoconstriction. Our experimental
results show that CMV infection is a risk factor to cause
cardiovascular diseases, specifically an increase of blood pressure
or hypertension. A non-lytic CMV infection and the perturbed
cellular gene expression, specifically the components of RAS,
underlie a molecular mechanism by which CMV infection causes
an increase of blood pressure.
In the in vivo mouse model study, we examined 48 mice of the
same species with the same age, similar body weight, and evenly
distributed male and female in 4 assay groups. We determined that
infection by MCMV induced an increase of blood pressure, and
Figure 6. Detection of MCMV DNA in specimens of blood vessels. The viral immediate early gene-1 (IE-1) DNA was detected in blood vessel
tissues of mice infected by MCMV. No viral IE-1 was detected in mice mock-infected and fed with either diet. The nested-PCR assay used two pairs of
viral specific primers that amplify the MCMV IE-1 gene into a 310-bp DNA fragment. (A–L) Lanes 1–12, the blood vessel tissues of twelve mice from
each experimental group. P, PCR positive control; N, PCR negative control. The positive rates of MCMV IE-1 in blood vessels of MCMV infected mice
are shown in Table 2.
doi:10.1371/journal.ppat.1000427.g006
Table 2. Detection of MCMV DNA in blood vessels.
IE-1 Aorta Carotid Postcaval Vein
+ 2 + 2 + 2
V+HD 12 0 8 4 12 0
HD 0 12 0 12 0 12
V1 1 1 6 6 1 2 0
M0 1 2 0 1 2 0 1 2
V+HD, mice infected by MCMV and fed with a high cholesterol diet. HD, mice
fed with a high cholesterol diet. V, mice infected by MCMV and fed a regular
diet. M, mice mock infected and fed a regular diet. Each group had 12 mice. The
MCMV DNA IE-1 was examined in three types of vessel cells of all experimental
mice. The numbers show the mice in each group positive and negative on the
viral DNA.
doi:10.1371/journal.ppat.1000427.t002
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PLoS Pathogens | www.plospathogens.org 9 May 2009 | Volume 5 | Issue 5 | e1000427compared this to the known risk factors of hypertension: high
cholesterol diet and atherosclerosis. We employed a catheter
method to measure the blood pressures of all assay mice, in the
right carotid under anesthesia to obtain an accurate reading and
reduce the pain of experimental animals. The mean values of
blood pressure of the MCMV infected mice were compared to the
control groups where the blood pressure was measured by the
same technique and the same procedure. The experimental results
show statistically significant differences between the MCMV
infected groups and the control groups. Clearly, our in vivo mouse
model study demonstrates that MCMV infection induced a
significant increase of arterial blood pressure, independent of the
other two known risk factors, high cholesterol diet and
atherosclerosis, in mice that were immune competent and with
normal lipid metabolic functions.
A high cholesterol diet induces an increase of blood pressure
in association with weight gain [30]. MCMV infection did not
contribute to a mouse weight gain (Fig. S1, P.0.05). The
weights of two groups of C57BL/6J mice fed with a high
cholesterol diet were greater than the two groups fed with a
regular diet (P,0.05), and both high cholesterol diet groups,
viral infected or not, had an increase of blood pressure (Fig. 1E).
The high blood pressure in overweight mice suggests that obesity
plays an important role in development of hypertension in mice
fed with high cholesterol diet. Obesity causes hypercholesterol-
emia, which results in high blood viscosity, blood dynamic
alterations, and vascular endothelial mechanistic injury. In our
study, MCMV infected mice had significantly increased blood
pressures compared to the mock-infected mice, in both diet
groups (P,0.01 and P,0.05). The MCMV infected group did
not weigh more than those in control groups fed with the same
diet (Fig. S1, P.0.05). Thus, CMV infection did not contribute
to the mouse weight gain, but caused an increase of blood
pressure apparently via a change in expression of cellular genes,
the over expression of inflammatory cytokines, renin and Ang II
in the vascular system.
Mice were infected with MCMV via the intra-peritoneal
injection. The viral IE-1 DNA was detected at week 6 post
infection in 100% of aortas of infected mice fed high cholesterol
diet, and in 92% of aortas of infected mice fed with a regular
diet. We also examined MCMV DNA in other blood vessels.
The majority of large vessels in the viral infected mice were
positive for viral DNA, and MCMV has an affinity to infect
vessel cells even though the port of viral infection is at the intra-
peritoneum (Fig. 6, Table 2). Aorta and postcaval vein appear to
be the main reservoirs of CMV. There was no significant
difference in MCMV infection of vessel cells in mice fed with a
high cholesterol diet compared to the mice fed with a regular
diet (P.0.05). Nerheim et al., however, have reported that the
active HCMV infection is enhanced in atherosclerotic blood
vessels compared to atherosclerosis-free vascular equivalents,
and this viral activity is restricted to the subpopulations of
intimal and adventitial cells [37].
Renin is a step limiting protein of RAS. Increased RAS activity
results in systemic hypertension and expression of ectopic anti-
renin or anti-angiotensin molecules decreases hypertension [24–
27]. We determined renin expression in both mouse and human
cells after CMV infection, and find that CMV infection increased
renin expression in cells in a MOI dependent manner (Fig. 4,
Fig. 7).
Furthermore, in immune competent individuals, CMV causes
persistent infections in certain types of cells, including EC. The
course of infection is symptomless, and limited at the cell level. In
our studies, all 4 groups of mice were followed for 10 weeks and no
symptoms of CMV infection were observed. Examination of
mouse specimens and infection of EC culture by CMV confirmed
that a non-lytic infection occurred in blood vessel cells (Fig. 2,
Fig. 8, Fig. S3, Fig. S4, Fig. S5).
In summary, CMV infection alone caused a significant increase
of arterial blood pressure. Enhanced expression of pro-inflamma-
tory cytokines, renin and Ang II underlies the pathogenic
mechanism of an active CMV infection to increase blood pressure
and aggravate atherosclerosis. Thus, control of CMV infection to
restrict development of hypertension and atherosclerosis may
provide a new strategy to prevent cardiovascular diseases
associated with HCMV infection.
Materials and Methods
Viruses
Mouse cytomegalovirus (MCMV, strain smith MSGV), was
purchased from American Type Culture Collection (ATTC, VR-
1399). MCMV stock was prepared by infection of mouse embryo
fibroblasts (ATCC CRL-1404) and collection of the culture
supernatant after cytopathic effect (CPE) was appeared on the
cell monolayer. The supernatants were centrifuged at 1,400 rpm
for 15 min to get rid of the cellular debris, and supernatants were
stored at 280uC in aliquots. The titer of the viral stock was
determined by the standard plaque assay [38]. The clinical isolates
of human cytomegalovirus (HCMV), BI-4 and BI-5, were
obtained from patient samples as previously described and
generously provided by Dr. Lurain (Rush University Medical
Center, Chicago, IL) [39]. The viral pool of laboratory strain
AD169ATCC was prepared from human fetal lung fibroblast
(MRC-5, ATCC) cell culture. Viruses were titrated on human
foreskin cells (HF, ATCC) following a consensus HCMV titration
protocol [40].
Study subjects
Two-week-old C57BL/6J mice (n=48) were obtained from
the Jackson Laboratory (Bar Harbor, Maine). Experiments
employed 2-week-old mice, housed in our animal facility with
3m i c e( t h es a m eg e n d e r )i no n ec a g e .M i c eh a df r e ea c c e s st ot a p
water, and fed with regular or atherogenic commercial diet
(1.25% cholesterol, 0.5% cholic acid and 15% fat), purchased
from the Jackson laboratory. All animal experiments were
Figure 7. HCMV infection of human EC induced expression of renin. (A) HCMV infection induced expression of renin mRNA, determined by
real time Q-RT-PCR assays. The expression of renin mRNA in cells showed correlation with an intensity of MOI 10.MOI 1, and cells with mock-
infection (MOI 0) served as the base line (RQ=1). (B) The products of Q-RT-PCR were confirmed by gel electrophoresis, showing that renin mRNA was
highly expressed in cells infected with MOI 10, in contrast to the cells infected with MOI 1 and MOI 0 (mock infection). (C) HCMV infection induced
renin expression in both venous (CRL-1730) and arterial (CRL-2472) EC, determined by PCR, RT-PCR and Western blot. To accurately measure the viral
replication and renin expression, HCMV DNA polymerase (pol) gene and the renin mRNA levels in infected cells were determined by PCR and RT-PCR,
respectively. Renin protein expressions were determined by Western blots in these cells. HCMV pol DNA was strongly detected in BI-5 (HCMV clinical
isolate) infected venous and arterial cells. AD169, a lab strain known to be unable to grow in vascular endothelial cells, served as a viral infection
control, which did not express viral pol gene nor induced renin expression. (D) HCMV BI-5 induced expression of renin mRNA in venous and arterial
EC, determined by real time Q-RT-PCR assays.
doi:10.1371/journal.ppat.1000427.g007
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guidelines. Protocols were approved by the Animal Care and
Use Committees of Beth Israel Deaconess Medical Center and
Harvard Medical School.
Experimental design of the mouse trial study
As is shown in Table 3.
Measurement of mouse blood pressure and collection of
specimen
Six weeks after MCMV infection (at week 10 of the experiment),
mice were anesthetized with pentobarbital sodium (40 mg/kg, IP).
The carotid artery was isolated and cannulated with a 1.4-Fr
(SPR-671) high-fidelity microtip transducer catheter connected to
a data acquisition system (PowerLab ML820, ADInstrument,
Colorado Springs) through a pressure interface unit (Millar
Instrument, Transducer Balance, TCB 600). The microtip
catheter was advanced into the carotid artery and carotid blood
pressure was recorded. The blood pressure data were collected
and analyzed using a Chart v4.1.2 software of AD-instrument
[28,29]. Then the end of carotid artery toward the heart was
ligated and the arteries were cut between two ligations (one end
toward heart and the other end toward brain). The fragment of
carotid artery was washed in PBS one time, and protein in O.C.T
medium then stored in liquid nitrogen. Following that,
200,400 ml of blood was collected from the jugular vein and
spun at 7,000 rpm for 10 minutes to remove cells. The plasma was
stored at 280uC. Aorta and postcaval vein were also collected,
washed with PBS to remove blood in vessels, and kept in liquid
nitrogen. The whole aorta was divided into three parts, of which
the root was used to prepare frozen sections and H&E stain for
pathology; the upper and lower chest fragment (about 0.5 to 1 cm)
were used for RNA extraction/gene analysis and DNA extrac-
tion/PCR assay, respectively.
Statistical analysis
Comparisons between 2 experimental groups were processed by
Student’s t test (2-tailed) and Chisquare (x
2) Test. P value#0.05
was considered statistically significant for a difference between
groups.
Immunofluorescent staining expression of renin and
MCMV antigen
The mouse kidney intraparenchymal cell line CRL-2193 (As4.1)
was purchased from ATCC. Cells have a basal level of
intracellularly secreted prorenin. To examine the effect of MCMV
infection on renin expression, the cells were infected with MCMV
and then allowed to grow in chambered slides for 5 days. The
culture slices were rinsed twice with PBS, and cells were fixed by
10% formaldehyde and permeabilized in 0.2% triton-X-100 in
PBS. Cells were incubated with 5% BSA (blocking reagent), and
then incubated further in PBS/5% BSA with 1:200 diluted
primary antibodies mouse anti-renin (Serotec), and mouse anti-
murine CMV (Express Biotech). After washing, the cells were
incubated with 1:300 diluted FITC-coupled anti-mouse IgG (Delta
Biolabs) or TRITC-coupled anti-mouse IgG (Invitrogen). The cells
were observed under a fluorescence microscope (Olympus, DP70)
after added mounting medium containing DAPI.
Angiotensin II ELISA
Angiotensin II ELISA kit was purchased from Bachem
(Torrance, CA) and sample testing followed manufacturer’s
instructions. The mouse serum was prepared as described in the
sample collection section. For detection of Ang II in vessel samples,
0.2 inch of aorta fragment of 3 randomly selected mice from each
group were diced and put in a 2-ml tube with 470 ml of lysis buffer,
respectively (20 mM HEPES, pH 7.5, 150 mM NaCl, 1% Triton
X-100, 0.1% SDS, 1 mM EDTA, 1 mM DTT, 2 tablets of Roche
protease inhibitor/50 ml). The tissues were then manually
disrupted in lysis buffer with a small pestle, respectively. The
solution was then incubated in 55uC overnight. After centrifuga-
tion, the supernatant of cell lysate was collected from each tube
and then used for detection of Ang II by ELISA.
Nested-PCR test of MCMV DNA in blood vessel cells
The vessel tissues were disrupted with a pestle in the tissue
digestive buffer (50 mM Tris-HCl, 100 mM NaCl, 5 mM EDTA,
1% SDS, 10 mg/ml Protease K) and digested at 50uC overnight.
After phenol and chloroform extraction, the DNA pellet was washed
with 70% alcohol, dissolved in 100 mld d H 2O, and kept in 280uC
till to PCR. The Nested PCR primers that amplify the MCMV
immediate early gene-1 (IE-1) are as previously described [41–43].
Table 3. Experimental design of the mouse trial study.
Group Quantity Week 0 Week 4 *Week 10
MCMV+Regular diet (V) 12 (F6+M6) Measure weight and
begin diet
MCMV infection, 300,000 pfu/1ml/mouse,
Intraperitoneal (IP)
Measure weight, blood pressure,
sacrifice mice and collect samples
and tissues
Mock infection+regular diet (M) 12 (F6+M6) Same as above Mock infection, 1ml PBS/mouse (IP) Same as above
MCMV+High cholesterol diet (V+HD) 12 (F6+M6) Same as above MCMV infection, 300,000 pfu/1ml/mouse,
Intraperitoneal (IP)
Same as above
High cholesterol diet (HD) 12 (F6+M6) Same as above Mock infection, 1ml PBS/mouse (IP) Same as above
*Week 6 post-infection. F: female. M: male. MCMV was diluted to above concentration with phosphate buffered saline (PBS).
doi:10.1371/journal.ppat.1000427.t003
Figure 8. Detection of HCMV ie1, ie2, pol, and pp65 mRNA in human EC. The viral gene expression was determined by RT-PCR assays at 14
days post infection. The pp65 gene expression served as the control. (A–E) HCMV RNA expression in infected umbilical vein cells (CRL-1730). (F–J)
HCMV RNA expression in abdominal aorta cells (CRL-2472). Data show that HCMV clinical isolates, BI-4 and BI-5, expressed viral specific genes and
persistently infected EC, whereas HCMV lab strain, AD-169, did not. The RT-PCR products examined by agarose gel are shown on the left panel, and
by densitometer tracing are shown on the right panel.
doi:10.1371/journal.ppat.1000427.g008
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TheReal-TimeRT-PCRwasperformedwithAppliedBiosystems
7300 Fast Real-Time PCR system using TaqMan probe and primer
based techniques. The probe and primers are specific to cDNA of
mouse and human renin, respectively, and were designed and
purchased from Applied Biosystems with the assay ID numbers
433734 (mouse) and 418327 (human). The Relative Quantification
(RQ) experiments were performed following the RQ protocol, and
results of RQ experiments are reported as the normalized reporter
dye fluorescence (Rn) as a function of cycle number for each sample,
compared to the internal control.
Cells and HCMV infection
Umbilical vein endothelial cell line (CRL-1730) and abdominal
aorta endothelial cell line (CRL-2472) were purchased from
ATCC. The log growth cells were split into 6-well plates two days
before CMV infection. After forming the monolayer, cells were
infected at multiplicities of infection (MOI) of 10 from each virus,
and the unadsorbed virus was washed off with PBS after
incubation. The supernatant of 0.5 ml from each culture was
collected at day 0, 3, 7, 10, and 14 post infection and replaced
back with 0.5 ml of fresh medium. Virus-induced cytolytic effect
was examined at each time point with the phase contrast
microscope. The COBAS amplicor CMV monitor test was
adapted to measure the HCMV pol DNA copy numbers in culture
supernatants, using the COBAS AMPLICOR Analyzer (Roche
Molecular Systems). This quantitative DNA PCR assay specifically
detects a 365-base fragment in HCMV pol gene that is not
homologous to other herpes viruses. The amplification kit was
purchased from Roche Diagnostic Systems, Inc. (Branchburg, NJ),
and specimen preparation, PCR amplification and HCMV DNA
quantification followed the manufacturer’s instructions.
RT-PCR examining expression of pp65, IE1, IE2, and pol
mRNA in infected cells
The RT-PCR primers were designed based on HCMV pp65, ie1
and ie2 (IE 55/86) exon sequences, respectively [42,43]. HCMV
pp65 forward primer: 59-CACCTGTCACCGCTGCTATATT
TGC-39; reverse primer: 59-CACCACGCAGCGGCCCTT-
GATGTTT-39.T h eie1 forward primers: 59-CTTAATACAAGC-
CATCCACA-39; reverse primer: 59-TAGATAAGGTTCAT-
GAGCCT-39.T h eie2 forward primer: 59-
GCACACCCAACGTGCAGACTCGGC-3; reverse primer: 59-
TGGCTGCCTCGA TGGCCAGGCTC-39.T h ep r i m e rs e tf o r
amplification of HCMV pol is the sameas that used inCOBAS assay
except the reverse transcription process, and amplifies a 365-base
fragment in HCMV pol gene that is not homologous to other herpes
viruses. RT-PCR was performed using OneStep RT-PCR kit
(Qiagen, Valencia, CA) according to manufacturer’s instructions.
The reaction mixtures were incubated in a thermocycler 9600 under
the following conditions: 50uC for 30 minutes, 95uC for 15 minutes,
and then 94uC for 30 second, 55uC for 30 second, and 72uCf o r
1 minute, total 35 cycles, finally 72uC for 10 minutes.
Extraction of total RNA from infected cells
Cells from each two wells (duplicate) were scraped and RNA
extraction and purification were followed the protocol of
purification of total RNA from animal tissues (RNeasy Mini Kit,
Qiagen Company). The On-Column DNase digestion was applied
to remove remaining DNA from the RNA samples (RNase-Free
DNase Set, Qiagen Company). The RNA concentration was
measured at the absorbance of O.D. 260, and the purity was
further examined by electrophoresis.
Supporting Information
Figure S1 Mouse weight change before and after experiment.
Weight changes of C57BL/6J mice before and after experiment.
HD, mean value of weights in the group of mice mock-infected
and fed a high cholesterol diet only. V+HD, MCMV-infected and
fed a high cholesterol diet. M, mock-infected and fed a regular diet
only. V, MCMV-infected and fed a regular diet.
Found at: doi:10.1371/journal.ppat.1000427.s001 (0.32 MB TIF)
Figure S2 Detection of MCMV IE1 mRNA in mouse aorta.
MCMV IE1 mRNA in murine aortas from 4 groups of mice tested
by RT-PCR. M, Molecular weight marker. Lanes 1–2: No
MCMV IE1 was detected in RNA samples of 2 mice in regular
diet group. Lanes 3–4: MCMV IE1 mRNA was detected in RNA
samples of 2 mice in MCMV infection plus regular diet group.
Lanes 5–6: No MCMV IE1 was detected in RNA samples of 2
mice in high cholesterol diet group. Lanes 7–8: MCMV IE1 was
detected in RNA samples of 2 mice in MCMV infection plus high
cholesterol diet group. P, RT-PCR positive control. N, RT-PCR
negative control. Extraction of total RNA was the same as
described previously. RT-PCR primers, Forward: 59
CCTCGAGTCTGGAACCGAAA 39; reverse: 59 TACAGGA-
CAAC AGAACGCTC 39. The total cellular RNA was reverse-
transcribed and cDNA product was amplified by PCR at 50uC
30 minutes, 95uC 15 minutes, and then 94uC 30 seconds, 55uC
30 seconds, and 72uC 1 minute for 35 cycles, with a final
extension at 72uC 10 minutes.
Found at: doi:10.1371/journal.ppat.1000427.s002 (0.41 MB TIF)
Figure S3 Non-lytic infection of venous EC by HCMV BI-4, BI-
5 and AD169. The morphology of CRL-1730 cells after HCMV
infection. (A) Day 1 post mock-infection. (B) Day 1 post BI-4
infection. (C) Day 1 post BI-5 infection. (D) Day 1 post AD169
infection. (E) Day 14 post mock-infection. (F) Day 14 post BI-4
infection. (G) Day 14 post BI-5 infection. (H) Day 14 post AD169
infection.
Found at: doi:10.1371/journal.ppat.1000427.s003 (1.61 MB TIF)
Figure S4 Non-lytic infection of arterial EC by HCMV BI-4,
BI-5, and AD169. The morphology of CRL-2472 cells after
HCMV infection. (A) Day 1 post mock-infection. (B) Day 1 post
BI-4 infection. (C) Day 1 post BI-5 infection. (D) Day 1 post
AD169 infection. (E) Day 14 post mock-infection. (F) Day 14 post
BI-4 infection. (G) Day 14 post BI-5 infection. (H) Day 14 post
AD169 infection.
Found at: doi:10.1371/journal.ppat.1000427.s004 (2.2 MB TIF)
Figure S5 HCMV persistently infects EC. Kinetic detection of
HCMV infection of EC by expression of pol gene. (A) Detection of
pol gene expression in venous EC (CRL-1730) infected by BI-4, BI-
5 and AD169. (B) Detection of pol gene expression in arterial EC
(CRL-2472) infected with BI-4, BI-5 and AD169. The EC were
infected by clinical isolates BI-4, BI-5 and lab strain AD-169 at an
MOI of 10, respectively. The supernatants of viral infected
cultures were harvested at each time point, and HCMV pol DNA
copy numbers were determined by the quantitative HCMV DNA-
PCR assays (COBAS). Results shown were from a representative
experiment of three performed, and data show that HCMV
clinical isolates persistently infected EC, in contrast to the lab
strain AD169.
Found at: doi:10.1371/journal.ppat.1000427.s005 (0.54 MB TIF)
Table S1 Blood pressures of C57BL/6J mice at week 4 and 10
of experiment (*base line). *The base line of blood pressure was
measured in the right carotid of each mouse at week 4 before the
MCMV infection, and mice were randomly selected from each
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rest of experiment. At week 10 of the experiment, the blood
pressures of these mice were measured again at the left carotids.
The ABp values of these mice at week 10 were not included in the
mean value of ABp measurement from each of the four
experimental groups that consisted of 12 mice in each group.
Found at: doi:10.1371/journal.ppat.1000427.s006 (0.03 MB
DOC)
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